Tilak Healthcare publishes clinical trial results on its mobile medical gaming app for tracking eye health.
Based in Paris, France, and San Francisco, California, Tilak Healthcare has announced the online publication of its first clinical trial results. The study, TIL-001, has been published in Ophthalmology and Therapy, a peer-reviewed, open access journal for ophthalmology.
OdySight is Tilak’s mobile medical game for remote monitoring of patients with chronic eye diseases. The aim of this study was to compare the medical modules of OdySight with the gold standard tests for visual health, including acuity, contrast sensitivity, and Amsler Grid. The results demonstrate good agreement with statistical significance, for the measurements taken by two of OdySight’s medical modules (visual acuity and Amsler grid) when compared to the gold standards. OdySight would be a good alternative for remote monitoring of vision between clinic visits, and could potentially assist in follow-up planning.
According to the study, there is a shortage of ophthalmologists worldwide, leading to a public health challenge for the approximate 285 million patients to find providers with time to see them. In the USA, there are approximately six doctors per 100,000 people.
The adoption and use of smartphones and other mobile devices is widespread, with 1.5 billion smartphones sold in the world in 2017 and 77% of Americans owning a smartphone. Study participation was offered to people who were visiting the hospital (Quinze-Vingts National Ophthalmology Hospital in Paris, France) for out-patient visits, as well as to their accompanying friends and family members. Each participant was noted to have one or multiple eye diseases, or none.
OdySight is a mobile medical video game available on a smartphone or tablet by prescription only. It contains a puzzle game as well as medical modules to test vision. A unique, patented technology using the front camera of the smartphone ensures that the tests are performed at a standardized distance and with adequate ambient light, as measured by the device. The results from the visual tests are sent via a secure server to an online dashboard which the physician can access in real time
Remote health monitoring tools may reduce patient stress, increase patient empowerment, and reduce overall costs, with potentially fewer unnecessary visits. In the field of ophthalmology, remote monitoring between clinic visits could detect progression of high-risk chronic disease before irreversible damage occurs.
The study authors include Tilak Healthcare’s co-founders, Professor José-Alain Sahel, Chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine & Director of the UPMC Eye Center, and Dr. Jean-François Girmens, a retina expert at the Quinze-Vingts National Ophthalmology Hospital in Paris.